ArticleBiomedicines2021

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis.

David Castro-Vazquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.